CONTEXT THERAPEUTICS INC (CNTX:NASDAQ)
$1.4 -0.02 (-1.4085%)
Analysed CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) News Sources
Context Therapeutics CEO Teases Q2 Claudin 6 Data, Nectin-4 Clinic Entry at TD Cowen Conference
08-03-2026
marketbeat.com
Context Therapeutics Outlines Post-ADC T-Cell Engager Strategy, Teases Q2 Claudin 6 Data
14-03-2026
marketbeat.com
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
19-03-2026
yahoo.com
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
23-03-2026
yahoo.com
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
02-04-2026
yahoo.com
Positive Signs As Multiple Insiders Buy Context Therapeutics Stock
27-04-2026
yahoo.com
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
06-05-2026
yahoo.com
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
18-05-2026
yahoo.com
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09-06-2026
yahoo.com
What is the current price of CONTEXT THERAPEUTICS INC (CNTX:NASDAQ)?
The current price of CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) is $1.4.
CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) since the previous trading day is $-0.02.
CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) since the previous trading day is -1.4085%.
What is the most recent average sentiment score for CONTEXT THERAPEUTICS INC (CNTX:NASDAQ)?
The most recent average sentiment score for CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for CONTEXT THERAPEUTICS INC (CNTX:NASDAQ)?
The most recent sentiment for CONTEXT THERAPEUTICS INC (CNTX:NASDAQ) is .
SEC-8K** Filing Available For CONTEXT THERAPEUTICS INC (CNTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.